Vertex Pharmaceuticals Inc / Ma
2014 Q2 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/30/2026 | 39,821 | 0.1% | 87,835 | 12/31/2025 |
| 2025 Q3 | 11/7/2025 | 35,298 | 0.1% | 90,129 | 9/30/2025 |
| 2025 Q2 | 7/31/2025 | 38,612 | 0.1% | 86,729 | 6/30/2025 |
| 2024 Q4 | 1/31/2025 | 38,364 | 0.2% | 95,267 | 12/31/2024 |
| 2024 Q3 | 11/4/2024 | 44,307 | 0.2% | 95,267 | 9/30/2024 |
| 2024 Q2 | 8/7/2024 | 44,654 | 0.2% | 95,267 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 61,661 | 0.2% | 147,511 | 3/31/2024 |
| 2023 Q4 | 2/2/2024 | 60,021 | 0.2% | 147,511 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 51,161 | 0.2% | 147,125 | 9/30/2023 |
| 2023 Q2 | 8/2/2023 | 53,315 | 0.2% | 151,502 | 6/30/2023 |
| 2023 Q1 | 4/26/2023 | 47,734 | 0.2% | 151,502 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 43,751 | 0.2% | 151,502 | 12/31/2022 |
| 2022 Q3 | 10/28/2022 | 43,510 | 0.2% | 150,274 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 42,009 | 0.2% | 149,078 | 6/30/2022 |
| 2022 Q1 | 5/3/2022 | 39,087 | 0.1% | 149,774 | 3/31/2022 |
| 2021 Q4 | 1/31/2022 | 33,517 | 0.1% | 152,629 | 12/31/2021 |
| 2021 Q3 | 10/27/2021 | 28,053 | 0.1% | 154,656 | 9/30/2021 |
| 2021 Q2 | 7/23/2021 | 31,396 | 0.1% | 155,712 | 6/30/2021 |
| 2021 Q1 | 4/27/2021 | 34,505 | 0.1% | 160,571 | 3/31/2021 |
| 2020 Q4 | 2/3/2021 | 40,477 | 0.1% | 171,268 | 12/31/2020 |
| 2020 Q3 | 10/27/2020 | 48,619 | 0.2% | 178,667 | 9/30/2020 |
| 2020 Q2 | 8/4/2020 | 53,550 | 0.2% | 184,459 | 6/30/2020 |
| 2020 Q1 | 6/19/2020 | 44,912 | 0.2% | 188,746 | 3/31/2020 |
| 2019 Q4 | 1/31/2020 | 41,326 | 0.2% | 188,746 | 12/31/2019 |
| 2014 Q2 | 8/11/2014 | 5,681 | 0.0% | 60,000 | 6/30/2014 |